{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:44:04Z","timestamp":1774352644089,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Merck Serono Spa Italy","award":["IST_MS 200136_0078"],"award-info":[{"award-number":["IST_MS 200136_0078"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clineuro.2020.106166","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T11:36:33Z","timestamp":1597923393000},"page":"106166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-5104","authenticated-orcid":false,"given":"Fioravante","family":"Capone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"De Vincentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-3738","authenticated-orcid":false,"given":"Francesco","family":"Motolese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Picardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Di Battista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Vespasiani-Gentilucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-5925","authenticated-orcid":false,"given":"Vincenzo","family":"Di Lazzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clineuro.2020.106166_bib0005","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.53.8.1622","article-title":"Multiple sclerosis: side effects of interferon beta therapy and their management","volume":"53","author":"Walther","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clineuro.2020.106166_bib0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1191\/1352458504ms1007oa","article-title":"Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes","volume":"10","author":"Tremlett","year":"2004","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.clineuro.2020.106166_bib0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/1352458506070893","article-title":"Acute liver failure in a patient with multiple sclerosis treated with interferon-beta","volume":"13","author":"Montero","year":"2007","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106166_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12883-017-0831-4","article-title":"Reasons for discontinuation of subcutaneous interferon \u03b2-1a three times a week among patients with multiple sclerosis: a real-world cohort study","volume":"17","author":"Sabid\u00f3-Espin","year":"2017","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2020.106166_bib0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00002018-200326110-00006","article-title":"Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance","volume":"26","author":"Francis","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.clineuro.2020.106166_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1212\/WNL.62.4.628","article-title":"Liver injury associated with the beta interferons for MS: a comparison between the three products","volume":"62","author":"Tremlett","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clineuro.2020.106166_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1352458510388823","article-title":"High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study","volume":"17","author":"Chan","year":"2011","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.clineuro.2020.106166_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"12","key":"10.1016\/j.clineuro.2020.106166_bib0045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106166_bib0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clineuro.2020.106166_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","author":"Tr\u00e9po","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106166_bib0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106166_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1665-2681(19)32043-5","article-title":"Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis","volume":"5","author":"Byrnes","year":"2006","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106166_bib0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: from bedside to bench","volume":"8","author":"Tujios","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.clineuro.2020.106166_bib0075","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10620-012-2553-1","article-title":"Presentation and outcomes with clinically apparent interferon beta hepatotoxicity","volume":"58","author":"Fontana","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106166_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.clineuro.2020.106166_bib0085","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clineuro.2020.106166_bib0090","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7564835","article-title":"Combining genetic variants to improve risk prediction for NAFLD and its progression to cirrhosis: a proof of concept study","author":"Vespasiani-Gentilucci","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.clineuro.2020.106166_bib0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPG.0000000000000279","article-title":"A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease","volume":"58","author":"Nobili","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106166_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.msard.2012.11.003","article-title":"The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis","volume":"2","author":"Kowalec","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106166_bib0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/tpj.2015.85","article-title":"Pharmacogenetic study of long-term response to interferon-\u03b2 treatment in multiple sclerosis","volume":"17","author":"Clarelli","year":"2017","journal-title":"Pharmacogenomics J."},{"issue":"2","key":"10.1016\/j.clineuro.2020.106166_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40263-018-0489-5","article-title":"Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment","volume":"32","author":"Solaro","year":"2018","journal-title":"CNS Drugs"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720305096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720305096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:35:50Z","timestamp":1759588550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720305096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"alternative-id":["S0303846720305096"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106166","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106166"}}